http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-935282-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_571b8abacacea64d3f7089d0983b8b3b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-215 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-215 |
| filingDate | 1959-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d59e6f6dbf13f100dee8fc147b6407d5 |
| publicationDate | 1963-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-935282-A |
| titleOfInvention | Improvements in and relating to sulphonyl ureas and their manufacture |
| abstract | The invention comprises N-3:4-dimethylphenylsulphonyl-N1-tetramethylene urea and salts, such as the sodium salt, thereof, and their preparation by treating pyrrolidine with a reactive carbonic acid derivative of 3:4-dimethylbenzenesulphonamide, such as ethyl 3:4-dimethylbenzenesulphonyl-carbamate, or by reacting 3:4-dimethylbenzenesulphonyl chloride with N-tetramethylene-O-alkylisourea and hydrolysing the resulting N-3:4-dimethylphenylsulphonyl-N1-tetramethylene-O-alkyl isourea with acid. Pharmaceutical preparations for the treatment of diabetes comprise the above compound or a salt thereof together with a pharmaceutical carrier. The Provisional Specification comprises N-phenylsulphonyl-N1-tetramethylene-ureas and salts thereof which carry methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy or bromine substituents in the 3- and 4-positions of the benzene ring. |
| priorityDate | 1959-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.